NanoString Technologies, Inc. announced three new Contract Research Organization (CRO) CosMxTM Spatial Molecular Imager partnerships. Macrogen, Propath UK, and Sirona Dx offer global biopharma customers new access to CosMx?? SMI technology for translational drug development.

These specialty CROs provide biomarker testing services for drug developers and academic research institutions. Propath in Hereford, UK is among the first global CROs to offer all three NanoString platforms: nCounter®? Analysis System, GeoMx®?

Digital Spatial Profiler and CosMx SMI. Their commitments highlight the demand for NanoString's platforms and the importance that global biopharma customers place on having access to multiple research tool options.